ArticleFrontiers in medicine2023

Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study.

Ekaterina Alexeeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.